Seevix
Seevix51About
What does Seevix do?
Seevix Material Sciences Ltd. is a biotechnology company that has developed a proprietary method for producing SVX, a synthetic spider silk protein. This protein offers exceptional strength, elasticity, and biocompatibility, making it suitable for a wide range of applications in industries such as medical devices, textiles, and advanced materials.
What is Seevix's revenue?
StartupHub estimates Seevix's annual revenue at $2.8M (range $1.5M to $6.5M, 65% confidence), based on comparable companies in the sector.
What is Seevix's valuation?
StartupHub estimates Seevix's effective valuation at $44.2M (range $27.5M to $66.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Seevix raised?
Seevix has raised a total of $11M in funding. The most recent round on record is Seed.
Where is Seevix headquartered?
Seevix is headquartered in Rehovot, Israel.
When was Seevix founded?
Seevix was founded in 2014.
What industry does Seevix operate in?
Seevix operates in Biotech, Life Sciences, Material Sciences, Synthetic Biology, Protein Engineering, Biomaterials.
How many employees does Seevix have?
Seevix has approximately 13 people on record.
No comments yet. Be the first to share your take.